News
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...
Researchers have identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk.
AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...
A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...
Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...
KERRY Joanne Wilkins was a "healthy" 35-year-old but died from liver failure - just three days after she first started showing symptoms. Her sister Jessica Matilda Wilkins, 31, is now questioning ...
wiping out teams working on research about adults with cognitive disabilities and sickle cell disease. Work likely to be halted by the cuts includes the collection of data for studying Americans ...
Human brain cells engineered to evade detection ... rats treated with a neurotoxin whose effects mimic the symptoms of Parkinson’s disease. Twelve weeks after the transplant, the rats’ muscle ...
Dr Garg adds, "Early diagnosis of Parkinson’s Disease allows for timely intervention with medications, lifestyle changes, and therapies that can ease symptoms and enhance quality of life.
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD ... the brain's resident immune cells, and have identified ...
According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results